Related Experiment Video
Updated: May 4, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Decreased serum bilirubin is associated with silent cerebral infarction
Rui-Yan Li1, Zhi-Gang Cao, Ji-Rong Zhang
1From the Departments of Neurosurgery (R.-Y.L.), Interventional Radiology (Z.-G.C.), and Geriatrics (J.-R.Z., Y.L., R.-T.W.) and International Physical Examination and Healthy Center (Y.L.), the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Insights
Lower total bilirubin (TB) levels are linked to a higher prevalence of silent cerebral infarction (SCI). Early measurement of TB may help assess SCI risk, independent of traditional cardiovascular factors.
Area of Science:
- Neurology
- Biochemistry
- Cardiovascular Medicine
Background:
- Silent cerebral infarction (SCI) is a known risk factor for stroke, dementia, and cardiovascular events.
- Lower total bilirubin (TB) levels have been associated with cardiovascular diseases, stroke, and peripheral arterial disease.
- The relationship between TB and SCI remains underexplored.
Purpose of the Study:
- To investigate the association between total bilirubin (TB) levels and the presence of silent cerebral infarction (SCI).
- To determine if TB can serve as a biochemical marker for SCI risk.
- To assess the correlation between TB and SCI independent of established cardiovascular risk factors.
Main Methods:
- A cross-sectional study involving 2865 participants undergoing medical checkups.
- Comparison of TB levels between participants with and without SCI.
- Partial correlation and multivariate logistic regression analyses were performed, adjusting for confounding covariates.
Main Results:
- Participants with SCI exhibited lower TB levels compared to those without SCI.
- A higher prevalence of SCI was observed in individuals with low TB levels.
- Higher TB levels were significantly associated with a reduced risk of SCI (OR, 0.925; P<0.001).
- TB levels showed a significant correlation with brachial-ankle pulse wave velocity (r=-0.149; P<0.001).
Conclusions:
- Total bilirubin (TB) is identified as a novel biochemical indicator for silent cerebral infarction (SCI).
- TB measurement may be a valuable tool for early risk assessment of SCI.
- The association between TB and SCI is significant, irrespective of classical cardiovascular risk factors.
Objective:
The presence of silent cerebral infarction (SCI) increases the risk of transient ischemia attack, symptomatic stroke, cardiovascular disease, and dementia. Total bilirubin (TB) levels were demonstrated to be decreased in carotid intima-media thickness, cardiovascular disease, stroke, and peripheral arterial disease. However, little information is available concerning the correlation between TB and SCI.
Approach And Results:
A cross-sectional study was conducted to evaluate the association between TB and SCI in 2865 subjects (1831 men and 1034 women) undergoing medical checkup. The participants with SCI had lower TB levels than those without SCI. The subjects with a low TB had a higher prevalence of SCI. Moreover, partial correlation showed that TB levels were tightly correlated with brachial-ankle pulse wave velocity after adjusting for confounding covariates (r=-0.149; P<0.001). Multivariate logistic regression analysis revealed that higher TB was associated with a lower risk of SCI (odds ratio, 0.925; 95% confidence interval, 0.897-0.954; P<0.001).
Conclusions:
TB is a novel biochemical indicator for SCI regardless of classical cardiovascular risk factors. Early measurement of TB may be useful to assess the risk of SCI.
More Related Videos
Related Concept Videos
Hepatic Encephalopathy
Jaundice
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Ischemic Stroke l: Introduction

